Medical News

RSS

Access Pharmaceuticals receives MuGard patent allowance

Access Pharmaceuticals, Inc has announced that the Company has received a "Notice of Allowance" letter from the United States Patent and Trademark Office for its patent application entitled "Liquid Formulations for the Prevention and Treatment of Mucosal Diseases and Disorders."

22 Jan 2007

Heska to sell allergy patents to Allergopharma

Heska Corporation has announced that it has completed the sale of its rights in a worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG for an undisclosed sum.

22 Jan 2007

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella, Inc. has announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SQ109, the company's proprietary lead drug candidate for treatment of pulmonary tuberculosis (TB).

22 Jan 2007

Novavax's pandemic flu vaccines show promise

Novavax, Inc.'s novel virus-like particle (VLP) vaccines have been shown to be effective in generating protection against pandemic influenza as well as cross protection against different strains of the virus in pre-clinical studies, according to data presented at the Phacilitate Vaccine Forum.

22 Jan 2007

Shire licenses the north American rights for Apricitabine to Avexa

Shire plc has announced that it licensed the North America (U.S. and Canada) rights for the investigational HIV compound, SPD754 (also known as apricitabine), to the Australian biotechnology company Avexa Limited in return for an up-front payment of US$10 million, development and sales related milestones and royalties.

22 Jan 2007

Measles Initiative exceeds goals

Measles deaths have fallen by 60% worldwide since 1999 - a major public health success. This exceeds the United Nations goal to halve measles deaths between 1999 and 2005 and is largely due to an unprecedented decline in measles deaths in the African region.

22 Jan 2007

Nanion continues opposition against Molecular Devices patent

Nanion Technologies GmbH, a supplier of automated, parallel patch-clamp systems based in Munich, Germany, has announced that they would appeal the decision of the European Patent Office (EPO) to uphold the disputed Molecular Devices patent EP 1,040,349.

22 Jan 2007

H5N1 genetic mutation observed in Egypt

Viruses with a genetic mutation, linked in laboratory testing to moderately reduced susceptibility to oseltamivir, have been discovered in two persons previously reported with H5N1 infections in Egypt.

22 Jan 2007

Nanoscale "egg" to deliver platinum to tumor cells

Researchers at the Hong Kong University of Science and Technology have developed a nanoscale "egg" that could safely deliver platinum, a known anticancer agent, to tumor cells.

22 Jan 2007

Nanoparticles from crab shells show promise for drug delivery

Nanoparticles made of chitosan, a naturally occuring polymer isolated from crab and shrimp shells, have shown promise as carriers of anticancer drugs, antitumor genes, and other novel therapeutic agents.

22 Jan 2007

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging

Iron oxide nanoparticles have shown promise as agents for detecting tumors using magnetic resonance imaging (MRI), but such efforts have been limited by the relatively weak magnetic signal generated by these nanoparticles.

22 Jan 2007

Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells

Taking a critical step toward the development of a multifunctional nanoscale anticancer agent that can detect cancer, treat it, and then report on the success or failure of that treatment, investigators at the University of Michigan have developed a nanoscale sensor of cell death.

22 Jan 2007

Lifestyle changes effective in protecting against Type 2 diabetes

Changing to a healthier lifestyle appears to be at least as effective as taking prescription drugs in reducing the risk of developing Type 2 diabetes, says a new British Medical Journal study.

18 Jan 2007

Improved effectiveness of partner notification for patients with sexually transmitted infections

Doctors should encourage patients with sexually transmitted infections to tell their partners to seek treatment and, in some cases, provide home testing kits or drugs to help reduce infection rates, says a new study on British Medical Journal website.

18 Jan 2007

Referral management schemes pose a serious threat to patients' interests

Referral management schemes are springing up across the NHS as a means of reducing primary care trusts' spending on secondary care services.

18 Jan 2007

Lessons from Vioxx litigation

The pharmaceutical industry, academia and government agencies need to work together to restore faith in drug development, say doctors in this weeks' British Medical Journal.

18 Jan 2007

Discovery of protein complex that plays important role in organ formation, cellular development and cicatrisation processes

Cellular movements are essential in organ formation processes, in cellular development and cicatrisation processes.

18 Jan 2007

Advanced Neuromodulation Systems receives European approval for Rapid Programmer

Advanced Neuromodulation Systems (ANS), the neuromodulation business of St. Jude Medical, Inc., has announced European CE Mark approval for its newest clinician programming platform, Rapid Programmer 3.0 for spinal cord stimulation (SCS), an advanced therapy for managing chronic pain.

18 Jan 2007

Most fertility clinic web sites do not conform to advertising guidelines

The majority of fertility clinic Web sites do not adhere to their own association's advertising guidelines, according to a University of Illinois at Chicago study published in the January issue of Fertility and Sterility.

18 Jan 2007

Combination therapy spares some head and neck patients from surgery

Giving patients with head and neck cancer a combination of chemotherapy and radiation therapy controls the cancer and allows many patients to avoid additional surgery to the neck.

18 Jan 2007